John V. Bosso, M.D., FAAAAI, FACAAI

faculty photo
Professor of Clinical Otorhinolaryngology: Head and Neck Surgery
Attending Physician, Clinical Professor, Hospital of the University of Pennsylvania
Director, Otorhinolaryngology: HNS Allergy Clinic, Department of Otorhinolaryngolgy: Head and Neck Surgery at the Perelman Center for Advanced Medicine, Hospital of the University of Pennsylvania
Medical Director, Penn AERD Center, Department of Otorhinolaryngology: Head and Neck Surgery at the Perelman Center for Advanced Medicine, Hospital of the University of Pennsylvania
Department: Otorhinolaryngology: Head and Neck Surgery

Contact information
Hospital of the University of Pennsylvania
Perelman Center for Advanced Medicine
South Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-360-0372
Fax: 215-662-4613
Education:
B.S. (Biochemistry, summa cum laude)
Saint Peter's University, Jersey City, New Jersey, 1981.
M.D. (Medicine)
Jacobs School of Medicine, University at Buffalo, Buffalo, New York, 1985.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

AERD/Samter's Triad
Chronic Rhinosinusitis
Nasal polyps
Aspirin/NSAID Allergy
Aspirin Desensitization
Biologicals for Asthma, CRS, Nasal Polyps
Immunotherapy for Allergic Diseases

Description of Research Expertise

AERD/Samter's Triad
Chronic Rhinosinusitis
Nasal polyps
Aspirin/NSAID Allergy
Aspirin Desensitization
Biologicals for Asthma, CRS, Nasal Polyps
Immunotherapy

Selected Publications

Workman Ad, Chang J, Lerner DK, Wilensky J, Montone KT, Bosso JV, Palmer JN, Adappa ND, Kohanski MA. : "Utilizing Histopathology to Predict Success with Macrolide Therapy in CRS Patients". Laryngoscope. 134(3): 1003-1004, March 2024.

Buckey TM, Bosso JV: "A Stepwise Approach to the adult immunodeficiency evaluation for the rhinologist". Curr Opin Otolaryngol Head Neck Surg 32(1): 50-54, Feb 2024.

Herzberg SD, Bosso AM, Sangal NR, Bosso JV: Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. M.Grayson (eds.). Science Direct, 131(4): 528-530, October 2023.

Kohanski MA, Qatanani A, Lin C, Tan LH, Chang J, Corr A, Herzberg S, Adappa ND, Palmer JN, reed DR, Bosso JV, Cohen NA. : Long-term aspirin desensitization has mucosal cytokine features of immune tolerance. Allergy Sep 20 2023 Notes: online ahead of print.

Lee DJ, Cramer HB, Kshirsagar RS, Douglas JE, Kohanski, MA, Palmer JN, Adappa ND, Bosso JV.: Dupilumab-related adverse events among patients with chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. T Smith (eds.). Wiley, 13(8): 1542-1545, August 2023.

Panara K, Grose E, Lee DJ, Safadi J, Douglas JE, Kohanski MA, Palmer JN, Lee JM, Adappa ND, Bosso JV : Readability and quality analysis of patient education materials in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol. T Smith (eds.). Wiley, June 2023 Notes: online ahead of print.

Douglas JE, Lin C, Mansfield CJ, Bell K, Salmon MK, Kohanski MA, Adappa ND, Palmer JN, Bosso JV, Reed DR, Cohen NA.: Genetics of denatonium-responsive bitter receptors in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol. Timothy Smith, MD (eds.). Wiley, 13(3): 269-272, March 2023.

Tripathi SH, Corr A, Kumar A, Ungerer H, Salmon M, Adappa ND, Bosso JV: SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD. Allergy Asthma Proc. J.Bellanti and R. Settipane (eds.). 44(1): 78-80, Jan 2023.

Douglas JE, Bosso JV: What's New in AERD? Am J Allergy Rhinol. R Sindwani, MD (eds.). Sage, 2023.

Sell EA, Tan LH, Lin C, Bosso JV, Palmer JN, Adappa ND, Lee RJ, Kohanski MA, Reed DR, Cohen NA. : Microbial metabolite succinate activates solitary chemosensory cells in the human sinonasal epithelium. Int Forum Allergy Rhinol. Timothy Smith, MD (eds.). Wiley, Page: Online ahead of print, Dec 2022.

back to top
Last updated: 04/12/2024
The Trustees of the University of Pennsylvania